<DOC>
	<DOCNO>NCT02607605</DOCNO>
	<brief_summary>The primary purpose study compare positive rate cell-free DNA cytological examination cerebrospinal fluid Advanced lung cancer leptomeningeal metastasis .</brief_summary>
	<brief_title>A Prospective , Observational Trial Diagnostic Prognostic LM</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<criteria>1 . Patient confirm primary lung cancer pathologic histology cytology 2 . Adult patient ( ≥18 year ≤75 year ) . ECOG Performance Status 0 1.Life expectancy least 12 week . 3 . Clinical symptom image test highly suspicious advanced lung cancer leptomeningeal metastases 4 . Without contraindication lumbar puncture 1 . Patients primary benign malignant brain tumor metastatic malignant brain tumor 2 . Patients contraindication lumbar puncture 3 . Serious uncontrolled systemic disease include active infection , uncontrolled hypertension , diabetes , unstable angina , congestive heart failure , myocardial infarction , severe arrhythmia need drug , hepatic、renal metabolic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>leptomeningeal metastasis</keyword>
	<keyword>cell-free DNA</keyword>
</DOC>